Bobby Hampton

I'll research this attorney's professional background before drafting.

Bobby Hampton — Patent Litigation Practice Summary

Focus areas. Hampton's tracked practice centers on medical-device patent litigation, specifically radiofrequency/neuromodulation devices for treating nasal conditions (chronic rhinitis). Both tracked matters arise from the same dispute between Neurent Medical and Aerin Medical/The Foundry over nasal ablation and neurotoxin-delivery technology — a mix of mechanical/electromechanical device art and life-sciences subject matter. Separate PTAB filings also list him on a WilmerHale IPR team for Maxeon (solar/photovoltaic technology), so his docket is not confined to a single technology vertical. He has also published on PTAB practice and patent-law reform topics (USPTO discretionary-denial and Director Review rulemaking, the Patent Eligibility Restoration Act) and authored an article on omnibus claims in the Federal Circuit Bar Journal (Vol. 33, No. 1, 2024).

Side preference. He works both sides. The tracked record shows one defendant-side appearance (Aerin Medical Inc. v. Neurent Medical Limited, where he represented the Neurent defendants as Counsel) and one plaintiff/petitioner-side appearance (Neurent Medical Inc. et al. v. The Foundry, LLC, as back-up counsel). In practice this means he has represented an operating medical-device company asserting and defending patents in the same campaign, rather than consistently prosecuting for NPEs/PAEs or consistently defending accused infringers. The sample size is small (two appearances), so no stronger pattern should be inferred.

Firm context. Both tracked appearances are at Wilmer Cutler Pickering Hale and Dorr LLP. No prior firm history was verified in available sources. Note that search results also surface a "Scott Hampton" of Hampton IP & Economic Consulting, an IP damages expert — a different individual with no apparent connection to this attorney.

Notable matters and outcomes. The central tracked dispute is Aerin Medical Inc. & The Foundry, LLC v. Neurent Medical Inc. & Neurent Medical Ltd., C.A. No. 23-756 (D. Del.), a consolidated action over eight Aerin/Foundry patents covering the Rhinaer/VivAer and Neuromark systems. Hampton appears on the Neurent side as Counsel. The district court case was stayed in August 2024 pending PTAB final written decisions; Aerin statutorily disclaimed asserted claims of the '597 and '194 patents in October 2024, and the Board instituted IPRs on the Aerin/Foundry patents in July 2024. In the related Neurent Medical Inc. v. The Foundry, LLC IPRs, the Board issued a final written decision (IPR2024-00669, July 21, 2025) holding all challenged claims of the '077 patent unpatentable, and a further Aerin Medical Inc. v. Neurent Medical appeal is docketed at the Federal Circuit (No. 25-2099). Individual attribution of these results to Hampton is not possible from the public record; he is one of several WilmerHale attorneys on the matters, alongside David Cavanaugh, Alexis Cohen, Alexander Nemtzow, Joshua Stern, Gilbert Smolenski, and Sarah Murphy.

PTAB / IPR experience. Yes — his tracked work and third-party listings place him on IPR teams, including as designated back-up counsel on a Maxeon-related petition (he was removed as back-up counsel by an October 16, 2025 update) and on the Neurent/Foundry IPR captions. He is a supporting, not lead, PTAB practitioner on the records reviewed; the petitions and hearings were argued by more senior WilmerHale counsel.

Bar / education. Not reliably sourced — no bar admissions or law-school information were located in the sources reviewed, so no line is included here. The above reflects only public filings and firm-authored publications; readers should verify current bar status and admissions directly.